Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aflatoxins are a group of highly toxic, carcinogenic, and mutagenic compounds produced by certain species of the Aspergillus fungus, primarily Aspergillus flavus and Aspergillus parasiticus. They contaminate agricultural crops and pose significant public health risks through dietary exposure. The most potent form is aflatoxin B1, which is metabolized into a reactive epoxide that binds DNA and proteins, leading to mutations and cellular damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aflatoxin.